Using a Prime-Boost Vaccination Strategy That Proved Effective for High Resolution Epitope Mapping to Characterize the Elusive Immunogenicity of Survivin

SIMPLE SUMMARY: The generation of tumor-specific T cells remains a pillar of modern cancer immunotherapy. Exogenous vaccines often rely on targeting tumor-associated antigens. The anti-apoptotic protein survivin has been deemed a high priority target due to its overexpression in a wide variety of tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Mould, Robert C., van Vloten, Jacob P., AuYeung, Amanda W. K., Walsh, Scott R., de Jong, Jondavid, Susta, Leonardo, Mutsaers, Anthony J., Petrik, James J., Wood, Geoffrey A., Wootton, Sarah K., Karimi, Khalil, Bridle, Byram W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699342/
https://www.ncbi.nlm.nih.gov/pubmed/34944889
http://dx.doi.org/10.3390/cancers13246270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699342/
https://www.ncbi.nlm.nih.gov/pubmed/34944889
http://dx.doi.org/10.3390/cancers13246270

Ejemplares similares